Catalent is looking to make a further commitment in the Tar Heel State — and will be building a new facility there.
The CDMO on Tuesday announced that it will build a new biologics analytical center in Durham, NC, a city just to the west of the capital and within the research triangle, a major area for drug manufacturing and laboratory work. The new facility will offer standalone analytical development and testing for biologics including cell and gene therapies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,